What does this research mean for the field?

Q: What does this research mean for the field?

Cardiac resynchronisation therapy (CRT), when combined with optimal pharmacological therapy, improves morbidity and mortality in selected heart failure patient populations. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

April 30, 2014Open Access

Current Evidence and Recommendations for Cardiac Resynchronisation Therapy

MDMatthew DewhurstNorth Tees and Hartlepool NHS Foundation Trust NLNicholas J. LinkerJames Cook University

Structured PICO

Does cardiac resynchronisation therapy (CRT) improve morbidity and mortality in selected heart failure patients?

Population

Selected symptomatic heart failure (HF) patient populations

Intervention

Cardiac resynchronisation therapy (CRT) combined with optimal pharmacological therapy

This review summarizes the established morbidity and mortality benefits of cardiac resynchronisation therapy in selected heart failure populations.

Abstract

The number of people in Europe living with symptomatic heart failure is increasing. Since its advent in the 1990s, cardiac resynchronisation therapy (CRT) has proven beneficial in terms of morbidity and mortality in selected heart failure (HF) patient populations, when combined with optimal pharmacological therapy. We review the evidence for CRT and the populations of HF patients it is currently shown to benefit, and those in which more research needs to be performed.

Perguntar à IA

Bookmark

View Full Paper

Cite This Study

Dewhurst et al. (Wed,) studied this question.

synapsesocial.com/papers/6a1bc42f4ebd09f3dfa8f813 https://doi.org/https://doi.org/10.15420/aer.2011.3.1.9

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Perguntar à IA

Bookmark

View Full Paper